Loading…
Journey Medical Corporation is projected to rise to $7.76 by 2027, a +12% move from its current price of $6.91. DERM is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $6.70 | $6.91 | $7.13 | +0.02% |
| Jul 15 | $6.61 | $6.91 | $7.23 | +0.04% |
| Jul 16 | $6.55 | $6.91 | $7.30 | +0.06% |
| Jul 17 | $6.49 | $6.92 | $7.36 | +0.08% |
| Jul 18 | $6.45 | $6.92 | $7.42 | +0.10% |
| Jul 19 | $6.41 | $6.92 | $7.47 | +0.12% |
| Jul 20 | $6.37 | $6.92 | $7.52 | +0.14% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.37 | $6.92 | $7.52 | +0.14% |
| Week 2 | $6.16 | $6.93 | $7.80 | +0.29% |
| Week 3 | $6.01 | $6.94 | $8.02 | +0.43% |
| Week 4 | $5.88 | $6.95 | $8.21 | +0.58% |
| Week 5 | $5.78 | $6.96 | $8.38 | +0.72% |
| Week 6 | $5.68 | $6.97 | $8.55 | +0.87% |
| Week 7 | $5.60 | $6.98 | $8.70 | +1.02% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Journey Medical Corporation is a healthcare company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
It markets a range of products including Qbrexza, a medicated cloth towelette for primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe recalcitrant nodular acne; Amzeeq, a topical minocycline formulation for inflammatory lesions of non-nodular moderate to severe acne vulgaris; Zilxi, a topical minocycline treatment for inflammatory rosacea; Emrosi for inflammatory rosacea; Exelderm cream and solution for fungal skin infections; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; and Luxamend, a moisture-preserving emulsion for wounds and burns.
The company was incorporated in 2014 and is headquartered in Scottsdale, Arizona.
Journey Medical Corporation trades in the healthcare sector with a current price of $7.04 and a market capitalization of $193.84M. It is ranked 3870 by market cap.
The latest 2026 forecast shows an average price of $7.04, with a min of $4.39 and a max of $9.72, a ROI of 0%, and a Neutral sentiment.
Longer-horizon projections show a rising trend: by 2030, the average is $11.63 (min $8.34, max $17.56) with ROI 65.2% and bullish sentiment; by 2040, the average is $28.32 (min $16.86, max $50.63) with ROI 302.3% and bullish sentiment; and by 2050, the average is $64.85 (min $33.27, max $128.14) with ROI 821.1% and bullish sentiment.
A major floor 36.5% below — a decisive break under it would weaken the trend.
The nearest floor, 14.3% below — buyers have tended to step in here.
The nearest ceiling, 4.5% above — a clean break opens room to run.
A major ceiling 18.4% above — clearing it would confirm fresh momentum.
Key DERM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DERM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.91 | Sell | $6.90 | Buy |
| MA 10 | $6.92 | Sell | $6.84 | Buy |
| MA 20 | $6.63 | Buy | $6.67 | Buy |
| MA 50 | $6.11 | Buy | $6.37 | Buy |
| MA 100 | $6.33 | Buy | $6.46 | Buy |
| MA 200 | $7.10 | Sell | $6.68 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 56.88 | Neutral |
| Stoch RSI (14) | 37.26 | Neutral |
| CCI (20) | 58.80 | Neutral |
| Williams %R (14) | -31.00 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | 3.13 | Buy |
| Bollinger %B (20,2) | 0.69 | Neutral |
| Stochastic %K (14) | 69.00 | Neutral |
| TRIX (15) | 0.58 | Buy |
| Awesome (5,34) | 0.50 | Buy |
| Ultimate (7,14,28) | 49.65 | Neutral |
| Momentum (10) | 0.69 | Buy |
| Aroon Osc (25) | 44.00 | Buy |
| Hull MA (9) | 6.81 | Buy |
| ADX (14) | 17.82 | Neutral |
| ATR (14) | 0.20 | Info |
The 30-day technical picture shows bullish orientation with RSI14 at 60. The 50-day simple moving average (SMA) is $5.89 and the 200-day SMA is $7.11.
The 30-day trading range spans from $5.69 to $8.71, with near-term support at $5.92 and resistance at $7.08. Annualized volatility stands at 60%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.39 | $6.91 | $9.55 | 0% | Neutral | |
| $6.09 | $7.76 | $10.51 | +12% | Neutral | |
| $6.30 | $8.30 | $11.72 | +20% | Bullish | |
| $6.94 | $9.39 | $13.70 | +36% | Bullish | |
| $8.08 | $11.19 | $16.78 | +62% | Bullish | |
| $10.30 | $14.59 | $22.39 | +111% | Bullish | |
| $10.56 | $15.28 | $23.96 | +121% | Bullish | |
| $9.96 | $14.69 | $23.48 | +113% | Bullish | |
| $11.36 | $17.06 | $27.75 | +147% | Bullish | |
| $11.51 | $17.60 | $29.11 | +155% | Bullish | |
| $16.72 | $27.73 | $49.09 | +301% | Bullish | |
| $33.44 | $63.95 | $124.92 | +825% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $4.39 | $6.91 | $8.48 | +0.00% |
| August 2026 | $6.06 | $7.18 | $8.76 | +3.92% |
| September 2026 | $5.89 | $7.04 | $8.70 | -1.95% |
| October 2026 | $5.96 | $7.17 | $8.95 | +1.84% |
| November 2026 | $6.20 | $7.50 | $9.45 | +4.61% |
| December 2026 | $6.18 | $7.52 | $9.55 | +0.25% |
Click any year to see its month-by-month DERM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, DERM is projected to trade between $4.39 and $9.55, averaging $6.91 — a potential gain of 0% from today's $6.91. A consolidation phase looks the most probable path here.
Journey Medical Corporation's 2027 outlook centres on $7.76, within a $6.09 to $10.51 range. That is up +12% on the projected 2026 average. That marks a +12% change versus current levels. Price action looks broadly range-bound.
By 2028, DERM could reach as high as $11.72, with a base case around $8.30 and support toward $6.30 — roughly +20% from $6.91. Buyers look set to stay in control over this stretch.
Expect DERM to range from $6.94 to $13.70 through 2029. The $9.39 average target implies a +36% move from current prices. That is up +13% on the projected 2028 average. Momentum favours further upside here.
The DERM price prediction for 2030 points to an average of $11.19 (low $8.08, high $16.78) — a potential gain of +62% on today's $6.91. Buyers look set to stay in control over this stretch.
In 2031, DERM is projected to trade between $10.30 and $22.39, averaging $14.59 — a potential gain of +111% from today's $6.91. That is up +30% on the projected 2030 average. Momentum favours further upside here.
Journey Medical Corporation's 2032 outlook centres on $15.28, within a $10.56 to $23.96 range. That is up +5% on the projected 2031 average. That marks a +121% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, DERM could reach as high as $23.48, with a base case around $14.69 and support toward $9.96 — roughly +113% from $6.91. Momentum favours further upside here.
Expect DERM to range from $11.36 to $27.75 through 2034. The $17.06 average target implies a +147% move from current prices. That is up +16% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The DERM price prediction for 2035 points to an average of $17.60 (low $11.51, high $29.11) — a potential gain of +155% on today's $6.91. Momentum favours further upside here.
In 2040, DERM is projected to trade between $16.72 and $49.09, averaging $27.73 — a potential gain of +301% from today's $6.91. That is up +58% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Journey Medical Corporation's 2050 outlook centres on $63.95, within a $33.44 to $124.92 range. That is up +131% on the projected 2040 average. That marks a +825% change versus current levels. Momentum favours further upside here.
Investing $1,000 in DERM today (≈ 144.7178 DERM) could be worth
$9,254.6
+$8,254.6 (+825%) by 2050 · US Dollar
Based on the average projected DERM price of $63.95 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DERMwould be worth at today's price.
$1,000 invested in DERM on Jul 10, 2025 (≈ 138.504159 DERM) would be worth
$957.06
-$42.94 (-4.3%) today · 0.96× · US Dollar
Based on a DERM entry price of $7.22 vs. today's $6.91.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $7.09 | $974.61 | -2.5% |
| 1 month ago | $6.07 | $1,138.39 | +13.8% |
| 3 months ago | $5.17 | $1,336.56 | +33.7% |
| 6 months ago | $7.74 | $892.76 | -10.7% |
| 1 year ago | $7.22 | $957.06 | -4.3% |
| All time (4.7y) ago | $9.9 | $697.98 | -30.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DERM forecast.
Our base-case forecast reaches $14.00 around 2031.
Implied market cap at $14.00: $301.48M
The multi-year forecast points to a substantial upside from the 2026 baseline, with rising averages and ROIs across the horizon. In 2026 the average is $7.04 with ROI 0 and Neutral sentiment, while 2029 shows an average of $9.48 and ROI 34.7 with bullish sentiment.
By 2030 the average is projected to $11.63 with ROI 65.2 and bullish sentiment. The forecast extends to 2040 with an average of $28.32 and ROI 302.3, and to 2050 with an average of $64.85 and ROI 821.1, both bullish. These figures imply meaningful upside but remain estimates, not guarantees, and are subject to market conditions and other risks.
Tap a question to reveal the answer.
The forecast shows an average price of $11.63 with a min of $8.34 and a max of $17.56; ROI 65.2%; sentiment BULLISH.
Forecasts show bullish sentiment for 2029, 2030, 2040, and 2050 with rising averages and ROIs (e.g., 2029 ROI 34.7% and 2050 ROI 821.1%), but 2026 shows ROI 0% and Neutral sentiment—these are estimates, not guarantees.
The 2040 forecast lists a max of $50.63 and an average of $28.32, indicating it could approach that level within the forecast, though not guaranteed.
The current price is $7.04 per share; market cap is $193.84M; rank is 3870.
By 2050 the average price is $64.85 with a max of $128.14 and ROI 821.1; sentiment is BULLISH.
Journey Medical Corporation Community Discussion
0Share your Journey Medical Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.